SANA Sana Biotechnology Inc

$SANA — Big day for Sana with new type 1 diabetes cell-therapy research being presented today. The entire thesis here is fascinating: creating replacement insulin-producing cells that can potentially evade the immune system, with the long-term goal of avoiding chronic immunosuppression. Still early and high risk, but successful immune-evasive cell replacement would be a huge development for the field.

$SANA I initiated a stake in $IPSC yesterday, and will be DCA for the next month into it. Their 29 day manufacturing and cold storage for transport has piqued my interest enough to invest. I am also very concerned right now they beat Sana to the punch of the first person cured, BUT fact is they carry more risk with it even working in human. My T1D Investments according to size right now: 1)$SANA - by far the largest, and plan to add more as data progresses. 2)$ELDN - Decent chunk. Tego is the ultimate back up, and I see it as a very important gap filler between HIP islets to kidneys, to livers, to lungs, to hearts, and anything else that is going to take time to develop over the next 2-3 decades. Current immunosuppression, Tacrolimus, is toxic and the side effects suck. God forbid with my very progressed CKD, I also may need tego for a kidney someday. I pray not though. 3)$IPSC Micro 1-2% of $ at most. F!!! I maybe picked the wrong horse play as a 50 yr T1D science man. GLA

$SANA SANA BIOTECHNOLOGY CO-FOUNDER GEOFFREY VON MALTZAHN SET TO JOIN PRESIDENT TRUMP AT WHITE HOUSE “SCIENCE: A NEW GOLDEN AGE” SUMMIT (Posted on X - not confirmed)

$SANA — Sana is presenting new type 1 diabetes work today at EASD around engineered donor insulin-producing cells designed to function without chronic immunosuppression.

$SANA lmao, cure for what ? These people don't have anything but a bunch of empty promises so they can keep taking your money

$SANA Dr.Harr, how do you intend to finance the next stages of SC451 without imposing another round of painful dilution on shareholders?

$SANA down 93% from inception. Pretty strange for a company that HaS tHE CUre FoR DiABEeTuS

$SANA thanks for all the input, CTA and Brian, etc. it also seems to be driven by economics. If a high percentage of cells are destroyed right away after being put in the liver, that means Sana would have to increase ots dose to account for that. Then, Sana would be treating a far less # of patients which is a huge problem since it will be capacity constrained for years, anyway, as it scales up.

$SANA $IPSC Sana delivering intramuscularly. Century putting cells into liver. Any thoughts on that distinction Brian?

$SANA Surprised no press release on the presentation this morning of updated UP421 data in Europe at EASD.

$SANA zero chance of commercial success for type 1 diabetics. They can’t manufacture islet cells and can’t harvest enough donors. Great idea until reality sets in.

$SANA Considering the markets muted/mostly flat reaction, I'm assuming that whatever was presented at Fridays EASD presentation was "as expected" Has anyone found any details?

$SANA it's called capitalism and fake it until you make it. Today though, I think some shorts could not push it down enough. They got too greedy.

$SANA all kinds of scientific promises, but Harr has failed to finance those promises responsibly.

$SANA Milan headline: Can HIP-engineered pancreatic cells survive and function inside a human without immunosuppression? So far: very encouraging evidence that they can.

$SANA to allow SANA to fund their salaries with your money, and because it may be too late to avoid the fleecing.

$SANA we are in a bad flow now. Why is sana so bad in communication? The issue seems to be bringing correct cells in big amounts. Any thoughs here? Sorry for my lack of english. Im just a t1ddad from sweden.